What's in Instituto do Coracao's pipeline?

Instituto do Coracao has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Instituto do Coracao's portfolio?

Top competitors by shared drug class: Colette Curtis MD, Sahiwal medical college sahiwal, Sisli Hamidiye Etfal Training and Research Hospital, University of Texas Southwestern Medical Center, Zhejiang Cancer Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-do-coracao.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Instituto do Coracao — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto do Coracao pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ropivacaine 0.2% + Dexamethasone	Ropivacaine 0.2% + Dexamethasone	phase 3	Local anesthetic with corticosteroid adjuvant	Voltage-gated sodium channels (ropivacaine); glucocorticoid receptor (dexamethasone)	Anesthesia / Pain Management

Therapeutic area mix

Anesthesia / Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Colette Curtis MD · 1 shared drug class
Sahiwal medical college sahiwal · 1 shared drug class
Sisli Hamidiye Etfal Training and Research Hospital · 1 shared drug class
University of Texas Southwestern Medical Center · 1 shared drug class
Zhejiang Cancer Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Instituto do Coracao:

Cite this brief

Drug Landscape (2026). Instituto do Coracao — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-do-coracao. Accessed 2026-06-10.